KN069
/ Alphamab, Xiamen Amoytop Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 05, 2024
A Study to Evaluate Features of KN069 in Participants With Obesity or Overweight
(clinicaltrials.gov)
- P1 | N=36 | Recruiting | Sponsor: Suzhou Alphamab Co., Ltd. | Not yet recruiting ➔ Recruiting
Enrollment open • Genetic Disorders • Obesity
1 to 1
Of
1
Go to page
1